# Juren Capital

> Juren Capital is a VC fund in Hangzhou backing Health Care and Biotechnology. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 10
- Last investment: Apr 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E6%B5%99%E6%B1%9F%E4%B9%9D%E4%BB%81%E8%B5%84%E6%9C%AC%E7%AE%A1%E7%90%86%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
- Website: http://www.jurencapital.com/

Juren Capital is a VC fund in Hangzhou focused on Health Care and Biotechnology. Juren Capital was founded in 2013 with 50,000,000 RMB registered capital .Juren Capital proudly has 8 influencial enterprises as their shareholders. They focus on Private Equity investment, Merging & Acquisition, Strategical Consulting and other Financial Advisement services .

## Contacts

5 contacts available for Juren Capital. Shizune tracks 6 team members at Juren Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/juren-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 20% |
| Biotechnology | 2 | 20% |
| Manufacturing | 2 | 20% |
| Medical Device | 2 | 20% |
| Energy | 1 | 10% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 30% |
| Series A | 2 | 20% |
| Series C | 2 | 20% |
| Angel | 1 | 10% |
| Funding Round | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Baotong Wang | President & CEO | 0 | — |
| Lijun Wang | Vice President | 0 | — |
| Qingfang Zhu | CFO | 0 | — |
| Shengang HUANG | CEO | 0 | — |
| Songqi LIU | President Assistant | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GenomePrecision | Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA"five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform. | $30.7M | Series C | Apr 19, 2021 |  |
| GenomePrecision | Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA"five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform. | $14.2M | Series B | Feb 18, 2019 |  |
| Das Security | Das Security provides information security product and service solution services. | $7.1M |  | Sep 29, 2017 |  |
| Microtech Medical | MicroTech Medical founded in January, 2011 in Hangzhou Future Technical City, which is the Industrial Garden for High-level Overseas Talents in Zhejiang Province, recieved capital from Eli Lilly and Company. They devote to innovate and manufacture high-tech and more affordable medical devices related to Diabetes Care. | $12M | Series B | Jan 01, 2017 |  |
| WT Microtech Medical | WT Microtech Medical mainly engaged in the R&D, production, sales and maintenance of the third category of medical devices. |  | Series B | Dec 09, 2016 |  |
| Microtech Medical | MicroTech Medical founded in January, 2011 in Hangzhou Future Technical City, which is the Industrial Garden for High-level Overseas Talents in Zhejiang Province, recieved capital from Eli Lilly and Company. They devote to innovate and manufacture high-tech and more affordable medical devices related to Diabetes Care. |  | Series B | Dec 09, 2016 |  |
| Juanpi | A fair price e-commerce platform for consumer daily needs, Juanpi is committed to providing consumers with affordable, high-quality goods and an individualized, enjoyable shopping experience. Juanpi believes in a balance between price and quality, and emphasizes fair price, good quality & well lifestyle. By introducing innovative model offair-price retail, Juanpi is dedicated to becoming the leading provider of fair-price quality goods, including Apparel, Digital products, Home goods and Maternity & Baby supplies.Juanpi acquires scenario-based insight to demands of consumers, ensuring chosen quality merchandise with its professional buyers and quality control team, and achieving surprising discounts through platform bargaining power. Established in Sept. 2012 in Wuhan, China. In 2015, Juanpi achieved a GMV of several billions CNY and a customer base of approximately 100 millions across Mobile App, PC Websites and WAP components, especially the mobile App contributed more than 80% of the total GMV. Each month, several thousands of retailers introduce special offers via Juanpi to customers with affordable, high-quality goods . In April of 2016, Juanpi completed the Series C funding with a total investment of 600 million CNY from Tiantu Capital, CMB International, together with Zhejiang Jinkong. In 2016, Juanpi continues to develop its fair-price retail market model and at the same time Juanpi sets its sights on overseas markets, promoting the unique model and concept to the world. With powerful business resources, professional buyers, dependable quality control team, cutting-edge technology and efficient operating capability, Juanpi has developed a brand new overseas e-commerce platform-- JUANPI, which has been available on Google Play and App Store worldwide since late June 2016. | $85M | Series C | Apr 15, 2016 |  |
| Zylox | Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson& Johnson, Medtronic, and Abbott before returning to China.Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices. | $6.4M | Series A | Nov 05, 2015 |  |
| Jinglei Corp | Jinglei Corp design and develops the position sensorless brushless DC motor compressor. Zhejiang fine electric appliance Limited by Share Ltd (hereinafter referred to as "fine thunder") was founded in 2002, is located in the beautiful northern Deqing County Zhejiang Mogan Mountain economic development zone. In September 2015 to achievethe new three board listing (Stock Code: 834095), by the national private enterprise 500 strong shield group control. Jing Lei electrical Limited by Share Ltd now in Huzhou City Mo Shan high tech Development Zone (national high tech Development Zone) covers an area of 75 acres, plant area of 35000 square meters. In 2005, our company began to design and develop the position sensorless brushless DC motor compressor jointly developed by Zhejiang University research and development team.After 12 years of unremitting efforts, and support the Dunan group, our company has ample liquidity and strong R & D team, which makes our products in performance and quality have been shaking leading domestic counterparts, and exported to Europe and other developed countries. Our company electric compressor series products have passed TS16949 certification, establish good cooperation relations and has numerous domestic and foreign new energy automobile manufacturers and a number of internationally renowned automotive air-conditioning enterprises.Fine ray Limited by Share Ltd to "the customer as the center, heart, brain, with the feelings of" for business purposes, to enhance economic efficiency continuously, continuously improve the product quality, professional technology and high-quality service for customers to bring the best product experience. With the continuous improvement of profitability, it has also been well received by customers both at home and abroad. At the same time, the group has developed a stable, continuous profit distribution program, and actively repay shareholders. Fine coal shares insist on paying taxes according to law, and the tax revenue created for the state has increased year by year. With its high starting point and high quality, Jing Lei has become the leader of the electric vehicle compressor industry in china. Zhejiang fine electrical appliance, Limited by Share Ltd is your ideal partner, we sincerely cooperate with you! |  | Series A | Apr 30, 2015 |  |
| 9188.com | 9188.com is an online lottery platform. | $425K | Angel | Oct 24, 2014 |  |

10 of 10 investments shown.

## Co-investors
- [CD Capital](https://shizune.co/investors/profile/cd-capital) — VC Fund, 3 deals together
- [Haiyuan Capital](https://shizune.co/investors/profile/goldport-capital) — VC Fund, 3 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 3 deals together
- [CrestValue](https://shizune.co/investors/profile/crestvalue) — VC Fund, 2 deals together
- [Oriental Fortune Capital](https://shizune.co/investors/profile/oriental-fortune-capital) — VC Fund, 2 deals together
- [China Growth Capital](https://shizune.co/investors/profile/china-growth-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Juren Capital invest in?

Juren Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Juren Capital?

Public channels for Juren Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Juren Capital?

The team at Juren Capital includes Baotong Wang (President & CEO), Lijun Wang (Vice President) and Qingfang Zhu (CFO), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co